Clinical Trial Update: Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for psilocybin in major depressive disorder; the Yale University study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Yale University | Conditions: Major Depressive Disorder | Phase 1 | Status: ACTIVE_NOT_RECRUITING